The company's press release is way to humble based upon the response we saw from the rep force using and selling the new product called "Vitality". More than one rep has reported that their personal share of business doubled in September. True it's not hard to go from 1 to 2, but the numbers of reps reporting dramatic increases was significant IMO. I'll stay long on NUS. Live with Intention
Good Morning Team - Bold emphasis = mine
Nu Skin Enterprises Reports Record Third-Quarter Results
(NYSE NUS) today announced record third-quarter results, with revenue of $383.6 million, a 15 percent improvement over the prior-year period. Earnings per share for the quarter were $0.55, a 38 percent improvement over the prior year.
"Our ageLOC anti-aging platform gives us a long-term competitive advantage with highly
innovative anti-aging solutions in both skin care and nutrition," said Truman Hunt, president
and chief executive officer. "We have now rolled out the ageLOC Transformation skin care
system in all of our markets and are generating strong, sustained revenue growth worldwide. We are particularly pleased with the emerging markets of South Asia/Pacific and Mainland China where we posted local currency revenue gains of 43 percent and 29 percent."
"In September we also initiated a limited-time offer of our first ageLOC nutritional product,
ageLOC Vitality, generating very encouraging results in Japan and the United States. Both
markets experienced revenue trend improvements during the quarter, benefiting from distributor enthusiasm surrounding the new ageLOC Vitality product."
"Given our strong performance, we are on pace to post another year of record revenue
and earnings," said Hunt. "We are creating healthy growth with our ageLOC anti-aging
platform, generating solid gains in our global business and making steady improvements
in operational efficiency.
"The catalyst for our growth over the past few years has been the infusion of ageLOC
anti-aging science into our skin care line. We are now taking the battle against aging 'inside'
with the introduction of ageLOC Vitality. Recognizing that one of the first signs of aging is
diminished energy levels, ageLOC Vitality is scientifically formulated to promote healthy gene activity associated with youthful energy production. The initial reaction to our limited-time offering of ageLOC Vitality was very promising, and we look forward to broadening distribution during the fourth quarter," concluded Hunt.
"We are raising our 2010 projected revenue and earnings per share guidance," said Ritch
Wood, chief financial officer.
Disclosure: Long NUS